Results 31 to 40 of about 350,390 (302)
Medicine in Drug Discovery, 2020 The COVID-19 pandemic, after it was reported in December 2019, is a highly contagious and now spreading to over 190 countries, causing a severe public health burden.
Jiayu Liao, George Way, Vipul Madahar
doaj +1 more source
ADME and Pharmacokinetic Properties of Remdesivir: Its Drug Interaction Potential
Pharmaceuticals, 2021 On 11 March 2020, the World Health Organization (WHO) classified the Coronavirus Disease 2019 (COVID-19) as a global pandemic, which tested healthcare systems, administrations, and treatment ingenuity across the world.
Subrata Deb +3 more
doaj +1 more source
Different COVID-19 treatments’ impact on hospital length of stay
European Journal of Medical Research, 2023 Importance COVID-19 has adversely affected global healthcare infrastructure since 2019. Currently, there are no large-scale published reports on the efficacy of combination therapy of dexamethasone, remdesivir, and tocilizumab on COVID-19 patients ...
Satori Iwamoto +8 more
doaj +1 more source
Psychopharmacological treatment in COVID-19 pandemic [PDF]
Klinik Psikiyatri Dergisi, 2020 The COVID-19 infection is still active both worldwide and in our country. Hereafter, it is going to have marked effects on clinical psychiatric practice. So, it is very important to consider the interactions of psychotropic drugs used in the COVID-19
Safiye Zeynep Tatlı +3 more
doaj +1 more source
Pharmaceutical Sciences and Research, 2020 Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can be aggravated by comorbid diseases.
Ana Khusnul Faizah +2 more
doaj +1 more source
Natural products as environmentally safe and green approach to combat Covid-19
Current Research in Green and Sustainable Chemistry, 2021 The Covid-19 pandemic is a major catastrophe in recent times that has taken a toll over the global scale in terms of the casualties, economic impact, and human beings' lifestyle.
Dheeraj Singh Chauhan +2 more
doaj +1 more source
Drug Repurposing in the Treatment of COVID-19
Bezmialem Science, 2020 The use of drugs that have been previously defined for certain indications in new indications is defined as the repurposing/repositioning of the drug. The requirement of all clinical research steps that starts from healthy volunteers, due to the slowness of new drug discovery, longer time to reach the market, and high cost to develop a new drug, make ...
Soylu, Mehmet +2 more
openaire +3 more sources
Teicoplanin: an alternative drug for the treatment of COVID-19?
International Journal of Antimicrobial Agents, 2020 In December 2019, a novel coronavirus, named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged from China causing pneumonia outbreaks, first in the Wuhan region of China and then spread worldwide because of its probable high transmission efficiency.
Baron, Sophie Alexandra +4 more
openaire +3 more sources
Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment [PDF]
Frontiers in Immunology, 2021 The magnitude of the coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has prompted the repurposing of several drugs to quickly stop the morbidity, mortality, and spread of this new disease.
openaire +4 more sources
Identifying side effects of commonly used drugs in the treatment of Covid 19
Scientific Reports, 2020 To increase the success in Covid 19 treatment, many drug suggestions are presented, and some clinical studies are shared in the literature. There have been some attempts to use some of these drugs in combination.
İrfan Aygün, Mehmet Kaya, Reda Alhajj
doaj +1 more source